Director/PDMR Shareholding

RNS Number : 2300W

Genedrive PLC

20 December 2021

 

PDMR Dealing

genedrive plc (LSE: GDR) ("genedrive" or the "Company"), the near patient molecular diagnostics company, announces that it has been notified of the following transaction by Matthew Fowler, a person discharging managerial responsibilities, and his wife who is a person closely associated with him.

Following the transfer outlined below, Matthew Fowler's total beneficial interest remains unchanged at 139,457 Ordinary Shares.

This notification is made in accordance with the Market Abuse Regulation. 

The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.

1.	Details of the person discharging managerial responsibilities / person closely associated
a.	Name	Matthew Fowler
2.	Reason for the notification
a.	Position/status	PDMR, CFO
a.	Initial notification /Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	genedrive plc
b.	LEI	213800ZYODIRZ87Y4K14
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument, type of instrument Identification code	Ordinary shares of 1.5 pence each GB00B1VKB244
b.	Nature of the transaction	Transfer of shares to Alison Fowler (spouse) for nil consideration.
c.	Price(s) and volume(s)	Price £nil Volume(s) 50,000
d.	Aggregated information · Aggregated volume · Price	50,000 Nil
e.	Date of the transaction	2021-12-20
f.	Place of the transaction	Outside a trading venue

For further details please contact:

genedrive plc	[phone]
David Budd: CEO / Matthew Fowler: CFO
Peel Hunt LLP (Nominated Adviser and Joint Broker)	[phone]
James Steel
finnCap (Joint Broker)	[phone]
Geoff Nash / Kate Bannatyne / Alice Lane
Walbrook PR Ltd (Media Relations & Investor Relations)	[phone] or [e-mail]
Paul McManus / Anna Dunphy	[phone] / [phone]

 

END

 

 

DSHEADAEAEKFFFA